• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过CT影像组学识别透明细胞肾细胞癌中的BAP1突变:初步研究结果

Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings.

作者信息

Feng Zhan, Zhang Lixia, Qi Zhong, Shen Qijun, Hu Zhengyu, Chen Feng

机构信息

Department of Radiology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Department of Radiology, Hangzhou First People's Hospital, Hangzhou, China.

出版信息

Front Oncol. 2020 Feb 28;10:279. doi: 10.3389/fonc.2020.00279. eCollection 2020.

DOI:10.3389/fonc.2020.00279
PMID:32185138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7058626/
Abstract

To evaluate the potential application of computed tomography (CT) radiomics in the prediction of BRCA1-associated protein 1 () mutation status in patients with clear-cell renal cell carcinoma (ccRCC). In this retrospective study, clinical and CT imaging data of 54 patients were retrieved from The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma database. Among these, 45 patients had wild-type and nine patients had mutation. The texture features of tumor images were extracted using the Matlab-based IBEX package. To produce class-balanced data and improve the stability of prediction, we performed data augmentation for the mutation group during cross validation. A model to predict mutation status was constructed using Random Forest Classification algorithms, and was evaluated using leave-one-out-cross-validation. Random Forest model of predict mutation status had an accuracy of 0.83, sensitivity of 0.72, specificity of 0.87, precision of 0.65, AUC of 0.77, F-score of 0.68. CT radiomics is a potential and feasible method for predicting mutation status in patients with ccRCC.

摘要

评估计算机断层扫描(CT)影像组学在预测透明细胞肾细胞癌(ccRCC)患者中乳腺癌1号关联蛋白1()突变状态的潜在应用。在这项回顾性研究中,从癌症基因组图谱 - 肾透明细胞癌数据库中检索了54例患者的临床和CT影像数据。其中,45例患者为野生型,9例患者有突变。使用基于Matlab的IBEX软件包提取肿瘤图像的纹理特征。为了生成类平衡数据并提高预测稳定性,我们在交叉验证期间对突变组进行了数据增强。使用随机森林分类算法构建预测突变状态的模型,并采用留一法交叉验证进行评估。预测突变状态的随机森林模型的准确率为0.83,灵敏度为0.72,特异性为0.87,阳性预测值为0.65,曲线下面积为0.77,F值为0.68。CT影像组学是预测ccRCC患者突变状态的一种潜在可行方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afc5/7058626/b9711250cb42/fonc-10-00279-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afc5/7058626/c9d04ce13828/fonc-10-00279-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afc5/7058626/b9711250cb42/fonc-10-00279-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afc5/7058626/c9d04ce13828/fonc-10-00279-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afc5/7058626/b9711250cb42/fonc-10-00279-g0002.jpg

相似文献

1
Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings.通过CT影像组学识别透明细胞肾细胞癌中的BAP1突变:初步研究结果
Front Oncol. 2020 Feb 28;10:279. doi: 10.3389/fonc.2020.00279. eCollection 2020.
2
Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.基于机器学习的非增强CT纹理分析预测透明细胞肾细胞癌的BAP1突变状态
Acta Radiol. 2020 Jun;61(6):856-864. doi: 10.1177/0284185119881742. Epub 2019 Oct 21.
3
Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.整合放射基因组学分析预测透明细胞肾细胞癌的分子特征和生存。
Aging (Albany NY). 2021 Mar 26;13(7):9960-9975. doi: 10.18632/aging.202752.
4
Imaging-genomic pipeline for identifying gene mutations using three-dimensional intra-tumor heterogeneity features.利用三维肿瘤内异质性特征识别基因突变的影像基因组流程。
J Med Imaging (Bellingham). 2015 Oct;2(4):041009. doi: 10.1117/1.JMI.2.4.041009. Epub 2015 Oct 6.
5
Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma.用于预测透明细胞肾细胞癌中 BRCA1 相关蛋白 1 和/或肿瘤蛋白 p53 基因突变状态的语义计算机断层扫描特征。
Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):666-675. doi: 10.1016/j.ijrobp.2022.12.023. Epub 2022 Dec 29.
6
Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status.透明细胞肾细胞癌的放射组基因组学:基于机器学习的高维定量 CT 纹理分析在预测 PBRM1 突变状态中的应用。
AJR Am J Roentgenol. 2019 Mar;212(3):W55-W63. doi: 10.2214/AJR.18.20443. Epub 2019 Jan 2.
7
Deep learning and radiomics: the utility of Google TensorFlow™ Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT.深度学习和放射组学:Google TensorFlow™ Inception 在多期 CT 上对透明细胞肾细胞癌和嗜酸细胞瘤分类的应用。
Abdom Radiol (NY). 2019 Jun;44(6):2009-2020. doi: 10.1007/s00261-019-01929-0.
8
Development of unenhanced CT-based imaging signature for BAP1 mutation status prediction in malignant pleural mesothelioma: Consideration of 2D and 3D segmentation.基于 CT 平扫影像特征的预测恶性胸膜间皮瘤 BAP1 突变状态的建立:二维和三维分割的考虑。
Lung Cancer. 2021 Jul;157:30-39. doi: 10.1016/j.lungcan.2021.04.023. Epub 2021 Apr 29.
9
Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.基于多期 CT 全相关放射组学特征对透明细胞和非透明细胞肾细胞癌的鉴别:从 VHL 突变角度。
Eur Radiol. 2019 Aug;29(8):3996-4007. doi: 10.1007/s00330-018-5872-6. Epub 2018 Dec 6.
10
A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.基于 CT 的影像组学列线图,用于区分无可见脂肪的肾血管平滑肌脂肪瘤与均质透明细胞肾细胞癌。
Eur Radiol. 2020 Feb;30(2):1274-1284. doi: 10.1007/s00330-019-06427-x. Epub 2019 Sep 10.

引用本文的文献

1
Identifying potential risk genes for clear cell renal cell carcinoma with deep reinforcement learning.运用深度强化学习识别肾透明细胞癌的潜在风险基因。
Nat Commun. 2025 Apr 15;16(1):3591. doi: 10.1038/s41467-025-58439-5.
2
Prediction study of surrounding tissue invasion in clear cell renal cell carcinoma based on multi-phase enhanced CT radiomics.基于多期增强CT影像组学的透明细胞肾细胞癌周围组织浸润预测研究
Abdom Radiol (NY). 2025 Jun;50(6):2533-2548. doi: 10.1007/s00261-024-04712-y. Epub 2024 Nov 26.
3
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.

本文引用的文献

1
Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.基于机器学习的非增强CT纹理分析预测透明细胞肾细胞癌的BAP1突变状态
Acta Radiol. 2020 Jun;61(6):856-864. doi: 10.1177/0284185119881742. Epub 2019 Oct 21.
2
CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma.CT 纹理分析:预测肾透明细胞癌 Fuhrman 分级的潜在工具。
Cancer Imaging. 2019 Feb 6;19(1):6. doi: 10.1186/s40644-019-0195-7.
3
Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics.
从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
4
A Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌常见基因组畸变中人群多样性的范围综述
Oncology. 2025;103(4):341-350. doi: 10.1159/000541370. Epub 2024 Sep 9.
5
Advancements in Radiogenomics for Clear Cell Renal Cell Carcinoma: Understanding the Impact of BAP1 Mutation.透明细胞肾细胞癌放射基因组学的进展:了解BAP1突变的影响
J Clin Med. 2024 Jul 6;13(13):3960. doi: 10.3390/jcm13133960.
6
The influence of manual segmentation strategies and different phases selection on machine learning-based computed tomography in renal tumors: a systematic review and meta-analysis.基于机器学习的计算机断层扫描在肾肿瘤中的手动分割策略和不同相位选择的影响:系统评价和荟萃分析。
Radiol Med. 2024 Jul;129(7):1025-1037. doi: 10.1007/s11547-024-01825-8. Epub 2024 May 13.
7
Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.孤立性胰腺透明细胞肾细胞癌转移的遗传和表观遗传特征。
Int J Mol Sci. 2023 Nov 14;24(22):16292. doi: 10.3390/ijms242216292.
8
Computed tomography texture-based models for predicting KIT exon 11 mutation of gastrointestinal stromal tumors.基于计算机断层扫描纹理的模型预测胃肠道间质瘤KIT外显子11突变
Heliyon. 2023 Oct 13;9(10):e20983. doi: 10.1016/j.heliyon.2023.e20983. eCollection 2023 Oct.
9
Deep learning techniques for imaging diagnosis of renal cell carcinoma: current and emerging trends.用于肾细胞癌成像诊断的深度学习技术:现状与新趋势
Front Oncol. 2023 Sep 1;13:1152622. doi: 10.3389/fonc.2023.1152622. eCollection 2023.
10
Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study.当使用特征组选择策略来预测透明细胞肾细胞癌的分子和临床靶标时,放射组学模型的可解释性得到提高:来自 TRACERx Renal 研究的见解。
Cancer Imaging. 2023 Aug 14;23(1):76. doi: 10.1186/s40644-023-00594-3.
验证一种补偿影响 CT 放射组学的多中心效应的方法。
Radiology. 2019 Apr;291(1):53-59. doi: 10.1148/radiol.2019182023. Epub 2019 Jan 29.
4
Radiogenomics in Clear Cell Renal Cell Carcinoma: Machine Learning-Based High-Dimensional Quantitative CT Texture Analysis in Predicting PBRM1 Mutation Status.透明细胞肾细胞癌的放射组基因组学:基于机器学习的高维定量 CT 纹理分析在预测 PBRM1 突变状态中的应用。
AJR Am J Roentgenol. 2019 Mar;212(3):W55-W63. doi: 10.2214/AJR.18.20443. Epub 2019 Jan 2.
5
Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice.肾细胞癌的分子分类及其在未来临床实践中的意义。
Kidney Cancer. 2017 Jul 26;1(1):3-13. doi: 10.3233/KCA-170008.
6
Radiogenomics in renal cell carcinoma.肾癌的放射基因组学。
Abdom Radiol (NY). 2019 Jun;44(6):1990-1998. doi: 10.1007/s00261-018-1624-y.
7
Radiomics of CT Features May Be Nonreproducible and Redundant: Influence of CT Acquisition Parameters.CT 特征的放射组学可能是不可重现和冗余的:CT 采集参数的影响。
Radiology. 2018 Aug;288(2):407-415. doi: 10.1148/radiol.2018172361. Epub 2018 Apr 24.
8
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.VHL基因改变在肾细胞癌中的预后及预测价值:一项荟萃分析与综述
Oncotarget. 2017 Feb 21;8(8):13979-13985. doi: 10.18632/oncotarget.14704.
9
Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.基于定量放射组学方法的II级胶质瘤非侵入性异柠檬酸脱氢酶1(IDH1)突变估计
Eur Radiol. 2017 Aug;27(8):3509-3522. doi: 10.1007/s00330-016-4653-3. Epub 2016 Dec 21.
10
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.一项比较一线依维莫司和舒尼替尼治疗转移性肾细胞癌患者的随机试验的基因组生物标志物
Eur Urol. 2017 Mar;71(3):405-414. doi: 10.1016/j.eururo.2016.10.007. Epub 2016 Oct 15.